Company Overview More
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company’s lead product candidates include RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors; RLY-4008, an oral small molecule selective inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced solid tumors having oncogenic FGFR2 alterations; and RLY-PI3K1047, a lead compound that targets cancer-associated mutant variants of phosphoinositide 3-kinase alpha. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

RLAY Relay Therapeutics Inc

34.110-2.510-6.85%
Close 10/15 19:20 ET
34.140+0.03+0.09%
Post Mkt Price 10/15 18:13 ET
High
36.800
Open
36.730
Turnover
41.04M
Low
33.250
Prev.Close
36.620
Volume
1.20M
Market Cap
3.16B
P/E(TTM)
8.36
52Wk High
64.370
Shares
92.70M
P/E
Loss
52Wk Low
25.720
H Mkt Cap
2.09B
Bid-Ask Ratio
25.93%
Historical High
64.370
H Shares
61.35M
Vol. Ratio
0.34
Historical Low
25.720
Dividend TTM
--
Div Yield TTM
--
P/B
5.11
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.96%
Amplitude
9.69%
Avg Price
34.091
Min Trading Unit
1
Float Market Cap
2.09B
Bid-Ask Ratio
25.93%
Historical High
64.370
Float
61.35M
Vol. Ratio
0.34
Historical Low
25.720
Dividend TTM
--
P/B
5.11
Dividend LFY
--
Turnover Ratio
1.96%
Amplitude
9.69%
Avg Price
34.091
Min Trading Unit
1
Price Forecast

Loading...

News